Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)
Shattuck Labs, Inc. (NASDAQ:STTK) is one of the best performing small cap stocks so far in 2026. Cantor Fitzgerald initiated coverage of Shattuck Labs, Inc.
Shattuck Labs Inc. (STTK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Persistent Asset Partners Xin Huang | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 62,500 | $250,000.00 | 318,608 | 2026-06-09 | Filing | |
| $0.87 | 1,051,021 | $911,970.92 | 1,051,021 | 2025-08-25 | Filing | |
| $0.87 | 5,255,106 | $4,559,855.48 | 5,255,106 | 2025-08-25 | Filing | |
| $0.87 | 1,051,021 | $911,970.92 | 1,051,021 | 2025-08-25 | Filing | |
| $0.87 | 5,255,106 | $4,559,855.48 | 5,255,106 | 2025-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.01 | 410 | $2,874.10 | 86,380 | 2026-07-02 | Filing | |
| $7.07 | 100 | $707.00 | 86,380 | 2026-07-01 | Filing | |
| $7.08 | 23,365 | $165,424.20 | 86,380 | 2026-06-30 | Filing | |
| $7.01 | 30,000 | $210,300.00 | 136,219 | 2026-06-30 | Filing | |
| $7.01 | 2,032 | $14,244.32 | 81,258 | 2026-05-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,935,810 | $27,314,521 | 0% | |
| 2. | 1,871,442 | $12,987,807 | 0.14% | |
| 3. | 1,430,167 | $9,925,359 | 2.29% | |
| 4. | 1,405,851 | $9,756,606 | 0.01% | |
| 5. | 1,026,394 | $7,123,174 | 0% |
News See All
10 Best Performing Small Cap Stocks So Far in 2026
Talking about the hiccup in tech, she was of the view that we are going to go through this over and over again, which includes worries about whether or not spending can keep up.
Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result
Highlighting the SL-325’s Phase 1 readout, expected in Q2 2026, H.C. Wainwright’s Joseph Pantginis reiterated a “Hold” rating on Shattuck Labs, Inc. (NASDAQ:STTK) on November 7, 2025.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks
On Tuesday, US stock futures remained stable, reflecting investor optimism following a significant rally in the technology sector on Wall Street, which drove the broader market to a new all-time high.
Shattuck Labs, Inc. (NASDAQ:STTK) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Shattuck Labs Third Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.
Shattuck Labs, Inc. (NASDAQ:STTK) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Shattuck Labs Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.
Shattuck Labs, Inc. (NASDAQ:STTK) Q3 2022 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to Shattuck Labs Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this article, we discuss the 5 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Hedge Fund Resource Center